Eurofins Biomnis is pleased to announce the availability of our Covid-19 serology test which enables the detection and quantification of G and/or M type antibodies in the serum of a patient who has been in contact with the virus.

These tests are performed by chemiluminescence technique and the SARS-CoV-2 antibodies detected are directed against targeted Spike (S) and Nucleocapsid (N) proteins.

Preanalytics and shipment

• Sample type: Serum
• Temperature : Refrigerated/Frozen if transport > 5 days
• Please fill in and attach the specific clinical information form
• TAT: 48 hours
• Results will be available on Biomnis Connect

Testing options

• IgG+IgM serology
• IgG serology
• IgM serology

For further information

• Covid-19 Factsheet INTGB
• Covid-19 Serology Clinical Information and test request form 

* Due to the need to increase testing capacity and ensure continuity of service in the event of a disruption in the reagent supply chain, we may be required to perform the analysis with other suppliers. These suppliers will be subject to the same strict performance validation process and we will provide you with information as appropriate.